Our report also showed that plasma levels of I-FABP were positively correlated with liver fibrosis measured by MRE and total CAC scores, reflecting the potential role of disrupted intestinal permeability in promoting adverse liver and cardiovascular events. Here, FABP2 is linked to Hepatic fibrosis.